Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
p-Cymene is a naturally occurring aromatic hydrocarbon belonging to the class of *aromatic monoterpenoids*. Its chemical structure features a benzene ring para-substituted with a methyl and an isopropyl group[5][7]. p-Cymene is found in many essential oils, notably cumin, thyme, and citrus peels[1][5][7]. It possesses **antioxidant**, **anti-inflammatory**, **antimicrobial** (antibacterial, antifungal), **antiparasitic**, **antidiabetic**, **analgesic**, **antitumor**, and **neuroprotective** properties[2][3][4][6]. Mechanistically, it acts mainly via inhibition of reactive oxygen/nitrogen species and modulation of inflammatory pathways(not targeting a single defined molecular protein), providing cytoprotective and anti-inflammatory effects[3]. It is approved as a flavoring agent (GRAS status in the US), and is used in pharmaceuticals (cough, bronchitis, indigestion, skin inflammation), cosmetics, food flavoring, agricultural chemicals, and as a bioactive ingredient in health supplements[2][4][6]. Research supports its potential in preventing protein glycation (diabetes complications), modulating immune responses, reducing pain and inflammation, and as a supportive therapy in oxidative stress–related diseases[2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on p-cymene.